13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001839435-24-000008
Total Value
$642.9M
Positions
42
Other Managers
0
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 3,006,980 | $86.7M | 13.49% |
| 2 | VERONA PHARMA PLC | 925050106 | 1,835,200 | $52.8M | 8.21% |
| 3 | STRUCTURE THERAPEUTICS INC | GPCR | 1,198,000 | $52.6M | 8.18% |
| 4 | DIANTHUS THERAPEUTICS INC | DNTH | 1,746,667 | $47.8M | 7.44% |
| 5 | ARRIVENT BIOPHARMA INC | AVBP | 1,976,387 | $46.4M | 7.22% |
| 6 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,012,052 | $32.2M | 5.00% |
| 7 | INSMED INC | INSM | 436,820 | $31.9M | 4.96% |
| 8 | NUVATION BIO INC | NUVB | 12,171,513 | $27.9M | 4.34% |
| 9 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 1,115,000 | $23.0M | 3.58% |
| 10 | OCULAR THERAPEUTIX INC | OCUL | 2,425,000 | $21.1M | 3.28% |
| 11 | VIRIDIAN THERAPEUTICS INC | VRDN | 870,000 | $19.8M | 3.08% |
| 12 | PERSPECTIVE THERAPEUTICS INC | CATX | 1,422,224 | $19.0M | 2.95% |
| 13 | INSMED INC | INSM | 250,000 | $18.3M | 2.84% |
| 14 | MIND MEDICINE MINDMED INC | 60255C885 | 3,018,000 | $17.2M | 2.67% |
| 15 | COGENT BIOSCIENCES INC | COGT | 1,305,000 | $14.1M | 2.19% |
| 16 | BRIDGEBIO PHARMA INC | BBIO | 552,000 | $14.1M | 2.19% |
| 17 | PHARVARIS N V | PHVS | 620,470 | $11.5M | 1.79% |
| 18 | DYNE THERAPEUTICS INC | DYN | 262,726 | $9.4M | 1.47% |
| 19 | TAYSHA GENE THERAPIES INC | TSHA | 4,572,222 | $9.2M | 1.43% |
| 20 | GOSSAMER BIO INC | GOSS | 9,187,883 | $9.1M | 1.41% |
| 21 | ALLOVIR INC | 019818103 | 11,202,000 | $9.1M | 1.41% |
| 22 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,093,503 | $8.7M | 1.36% |
| 23 | PRAXIS PRECISION MEDICINES I | PRAX | 130,000 | $7.5M | 1.16% |
| 24 | MINERALYS THERAPEUTICS INC | MLYS | 600,000 | $7.3M | 1.13% |
| 25 | REGULUS THERAPEUTICS INC | 75915K309 | 4,263,701 | $6.7M | 1.04% |
| 26 | VENTYX BIOSCIENCES INC | 92332V107 | 2,391,114 | $5.2M | 0.81% |
| 27 | TENAYA THERAPEUTICS INC | TNYA | 2,576,200 | $5.0M | 0.77% |
| 28 | CYBIN INC | HELP | 489,596 | $4.4M | 0.68% |
| 29 | RENEO PHARMACEUTICALS INC | 75974E103 | 2,250,000 | $3.8M | 0.59% |
| 30 | UNICYCIVE THERAPEUTICS INC | UNCY | 8,559,000 | $3.5M | 0.54% |
| 31 | PEPGEN INC | PEPG | 376,117 | $3.2M | 0.50% |
| 32 | HELIX ACQUISITION CORP II | HLXC | 250,000 | $2.6M | 0.41% |
| 33 | BLACK DIAMOND THERAPEUTICS I | BDTX | 594,000 | $2.6M | 0.40% |
| 34 | ANNEXON INC | ANNX | 400,000 | $2.4M | 0.37% |
| 35 | MERSANA THERAPEUTICS INC | 59045L106 | 992,000 | $1.9M | 0.29% |
| 36 | CENTURY THERAPEUTICS INC | IPSC | 666,825 | $1.1M | 0.18% |
| 37 | AEROVATE THERAPEUTICS INC | 008064107 | 465,440 | $972,770 | 0.15% |
| 38 | NUVATION BIO INC | NUVB | 312,336 | $715,249 | 0.11% |
| 39 | AUTOLUS THERAPEUTICS PLC | AUTL | 176,000 | $638,880 | 0.10% |
| 40 | NEUROGENE INC | NGNE | 15,000 | $629,400 | 0.10% |
| 41 | RAPT THERAPEUTICS INC | 75382E109 | 292,000 | $586,920 | 0.09% |
| 42 | NKARTA INC | NKTX | 120,000 | $542,400 | 0.08% |